Core Viewpoint - The article highlights the swift action taken by the Xiamen Market Supervision Administration in response to reports of false advertising related to "imported" blood sugar control drinks, leading to the removal of certain products from the market and ongoing investigations into the involved companies [1][4][5]. Regulatory Response - The Xiamen Market Supervision Administration has initiated an investigation into the companies involved in the false advertising of blood sugar control products, specifically targeting the "Kongtangwei" and "Breorqy" brands [1][5]. - The regulatory body has mandated the removal of product links and is conducting further investigations to address the reported violations [1][5][6]. Market Impact - The article notes that the false claims made by these products, such as being "imported" and having extraordinary effects on blood sugar control, misled consumers and posed challenges to diabetes treatment [4][5]. - The cost of the "Kongtangwei" product is estimated to be less than 10 yuan, while it is sold for over 100 yuan, indicating significant markup based on misleading claims [4]. Ongoing Issues - Despite the removal of certain products, many others continue to be sold with unchanged promotional content, indicating a persistent issue with false advertising in the market [7][8]. - The article points out that various other products, including chromium supplements and herbal teas, also make unverified claims regarding their effectiveness in controlling blood sugar levels [5][8]. Recommendations for Improvement - Experts suggest that regulatory efforts need to be strengthened, particularly in enhancing the oversight of e-commerce platforms to prevent the sale of products with exaggerated claims [8][9]. - There is a call for improved collaboration among regulatory bodies across different regions to ensure comprehensive monitoring and enforcement against misleading advertising practices [8][9].